Furthermore, HGF-c-MET signaling also leads to activation of the PI3K/AKT pathway [69] and AKT1 has been identified as a direct target of hsa-miR-637 in pancreatic ductal adenocarcinoma cells [70]. Here, AKT1 is linked to pancreatic ductal adenocarcinoma.